Form 4: SI-BONE CFO Anshul Maheshwari Sells Shares Under 10b5-1 Trading Plan

Anshul Maheshwari, CFO of SI-BONE, Inc., executed sales of common stock on May 7th and 8th, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Anshul Maheshwari, the Chief Financial Officer of SI-BONE, Inc., reported the sale of company stock on May 7th and 8th, 2025.
• The sales were executed under a 10b5-1 trading plan.
• On May 7th, 4,937 shares of common stock were sold at a weighted-average price of $17.0021, in transactions ranging from $17.00 to $17.03.
• On May 8th, 28,350 shares of common stock were sold at a weighted-average price of $18.1691, in transactions ranging from $18.00 to $18.37.
• Following these transactions, Maheshwari directly owns 237,006 shares of common stock.
• This includes 180,329 shares issuable on the settlement of restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating stock sales by an insider. The sentiment is neutral as it simply reports transactions without expressing any positive or negative views about the company's prospects.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of insider trading. The market typically views such sales in the context of the insider's overall holdings and the reasons behind the transactions.

Stakeholder Impact

• Shareholders may interpret the stock sales as a lack of confidence by the CFO, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

SI-BONE, Anshul Maheshwari, Form 4, Stock Sale, 10b5-1 Trading Plan, CFO, Insider Trading